Skip to main content
Skip to content
Case File
efta-efta01521445DOJ Data Set 10Correspondence

EFTA Document EFTA01521445

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01521445
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL ACCT. For the Period 11/1/12 to 11/30/12 Equity Summary Asset Categories US Large Cap Equity 58,158.40 56,855.01 (1,303.39) 1% US Small/Mk! Cap Equity 3,990.00 4,230.00 240.00 1% Non-US Equity 150.05 148.73 (1.32) 1% Preferred Stocks 449,211.00 450,196.00 9185.00 5% Concentrated 8 Other Equity 214,243.50 209,943.00 (4,300.50) 3% Total Value 5725,752.95 5721,372.74 ($4,380.21) 11% Beginning Ending Change Current Asset Categories Market Value Market Value In Value Allocation Market Value/Cost Current Period Value Market Value 721,372.74 Tax Cost 764,967.39 Unrealized Gain/Loss (43,594.65) Estimated Annual Income 45,693.48 Accrued Dividends 1,645.13 Yield 6.31% Equity Detail Non-USEpAry UsSrmItlitdCapEquoy US Lary Cap Equity Equity as a percentage of your portfolio - 11 % PreknvdStocks Concentrated a Other &way Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss red Iv. Yield US Large Cap Equity APACHE CORP 037411-10-5 APA 77.09 95.000 7,323.56 11,403.30 (4,079.75) 64.60 0.88% JP Morgan Page 5 of 32 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00048830 SDNY_GM_00318028 EFTA01521445

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.